Use of TpCO2 (Transcutaneous CO2 Measurement) as PaCO2 Predictor During NIV in Case of Acute Hypercapnic Respiratory Failure
CompletedOBSERVATIONAL
Enrollment
20
Participants
Timeline
Start Date
February 28, 2013
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2015
Conditions
Hypercapnic Respiratory Failure
Trial Locations (1)
1011
Intensive care and burn unit, University hospital of Lausanne, Lausanne
All Listed Sponsors
lead
University of Lausanne Hospitals
OTHER
NCT01857635 - Use of TpCO2 (Transcutaneous CO2 Measurement) as PaCO2 Predictor During NIV in Case of Acute Hypercapnic Respiratory Failure | Biotech Hunter | Biotech Hunter